Dexmedetomidine reduces in-hospital mortality in aneurysmal subarachnoid hemorrhage patients by modulating three key genes and inflammatory pathways: insights from clinical and bioinformatics analyses

BackgroundAneurysmal subarachnoid hemorrhage (aSAH) is a cerebrovascular disease with high mortality. Dexmedetomidine has a neuroprotective effect. This study aimed to explore the clinical and molecular association between dexmedetomidine and in-hospital mortality of aSAH.MethodsPatients with aSAH i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zhi-ang Li, Hong-cai Wang, Xue-wei Zhang, Li-hong Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-07-01
Colecção:	Frontiers in Neurology
Assuntos:	aneurysmal subarachnoid hemorrhage dexmedetomidine in-hospital mortality inflammation immune
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1554809/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!